Perrigo Ordinary Shares reported $10.92B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Aphria Inc APH:CN C$ 2.81B 5.48M
Bayer BAYN:GR € 116549M 2122M
Bristol Myers Squibb BMY:US $ 110893M 96M
Catalent CTLT:US $ 10183M 1071M
Coherus Biosciences CHRS:US $ 741.73M 2.18M
Corcept Therapeutics CORT:US $ 585.4M 16.92M
Eli Lilly And LLY:US $ 48187M 378M
Endo International Ordinary Shares ENDP:US $ 9246.55M 40.3M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Horizon Pharma HZNP:US $ 8608.69M 401.27M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Lannett LCI:US $ 690.87M 7.13M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Perrigo Ordinary Shares PRGO:US $ 10915.9M 314.4M
Phibro Animal Health PAHC:US $ 836.04M 5.28M
Prestige Brands PBH:US $ 3675.82M 116.7M
Supernus Pharmaceuticals SUPN:US $ 1555.04M 18.02M
Teva Pharmaceutical TEVA:IT 47.85B 1.34B
Xeris Pharmaceuticals Inc XERS:US $ 131.26M 20.24M
Zoetis ZTS:US $ 13705M 364M